Jazz Pharmaceuticals plc — Director's Dealing 2015

Sep 3, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2015-09-01

Reporting Person: ENRIGHT PATRICK G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-09-01	Ordinary Shares	S	2851	$164.51	Disposed	271649	Indirect
2015-09-01	Ordinary Shares	S	2846	$165.2659	Disposed	268803	Indirect
2015-09-01	Ordinary Shares	S	1169	$166.3572	Disposed	267634	Indirect
2015-09-01	Ordinary Shares	S	1081	$167.3287	Disposed	266553	Indirect
2015-09-01	Ordinary Shares	S	1857	$168.3373	Disposed	264696	Indirect
2015-09-01	Ordinary Shares	S	57	$164.5031	Disposed	5443	Indirect
2015-09-01	Ordinary Shares	S	57	$165.2569	Disposed	5386	Indirect
2015-09-01	Ordinary Shares	S	24	$166.3583	Disposed	5362	Indirect
2015-09-01	Ordinary Shares	S	21	$167.3168	Disposed	5341	Indirect
2015-09-01	Ordinary Shares	S	37	$168.3254	Disposed	5304	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	1734	Direct

Footnotes

F1: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $163.89 to $164.88. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F2: The Reporting Person is a managing member of Longitude Capital Partners, LLC, the general partner of each of Longitude Venture Partners, L.P. and Longitude Capital Associates, L.P. The Reporting Person disclaims beneficial ownership of the securities of the Issuer held by Longitude Venture Partners, L.P. and Longitude Capital Associates, L.P. except to the extent of his pecuniary interest therein.

F3: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $164.89 to $165.83. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F4: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $165.94 to $166.72. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F5: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $166.94 to $167.90. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F6: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $167.96 to $168.76. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F7: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $163.89 to $164.88. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F8: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $164.89 to $165.83. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F9: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $165.94 to $166.72. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F10: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $166.94 to $167.90. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F11: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $167.96 to $168.76. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.